RÉSUMÉ
BACKGROUND: People with diabetes mellitus, especially insulin-dependent diabetic patients, are a risk group for staphylococcal infections. Asymptomatic infection with Staphylococcus aureus is common and favors dissemination of the microorganism, rendering these individuals a source of infection. This study aimed to characterize the resistance profile, clonal profile and sequence type, as well as to analyze the prevalence and risk factors for nasal and oropharyngeal carriage of methicillin-susceptible (MSSA) and methicillin-resistant S. aureus (MRSA) isolated from insulin-dependent diabetic individuals in the city of Botucatu, SP, Brazil. METHODS: Staphylococcus aureus was collected from the nasopharynx and oropharynx of 312 community-dwelling insulin-dependent diabetic individuals over a period of 3 years (October 2015 to December 2018). The isolates were characterized by susceptibility profiling, detection of the mecA gene, SCCmec typing, and molecular typing by PFGE and MLST. The risk factors associated with S. aureus and MRSA carriage were determined by logistic regression analysis. RESULTS: The overall prevalence of colonization with S. aureus and MRSA was 30.4% and 4.8%, respectively. Fifteen of the 112 S. aureus isolates carried the mecA gene; SCCmec type IV was identified in 10 isolates, SCCmec type I in three, and SCCmec type II in two. Among the 15 resistant isolates (MRSA), four were susceptible to oxacillin/cefoxitin by the disc diffusion method and one MSSA isolate was resistant to sulfamethoxazole/trimethoprim. The analysis of risk factors revealed a protective effect of age and lung disease, while lower-extremity ulcers were a risk factor for S. aureus. For MRSA, only male gender was significantly associated as a risk factor in multivariate analysis. Clonal profile analysis demonstrated the formation of clusters among MRSA isolates from different patients, with the identification of ST5-IV, ST5-I, and ST8-IV. Isolates carrying ST398 were identified among MSSA and MRSA (ST398-IV). CONCLUSION: Our findings reinforce the importance of epidemiological studies of S. aureus carriage, especially in populations at high risk of infections such as diabetics. The data suggest widespread dissemination of MRSA in the population of insulin-dependent diabetic patients studied, as well as the emergence of important lineages among these individuals.
Sujet(s)
Diabète de type 1/microbiologie , Staphylococcus aureus résistant à la méticilline/génétique , Sujet âgé , État de porteur sain/épidémiologie , Études transversales , Électrophorèse en champ pulsé , Femelle , Humains , Mâle , Staphylococcus aureus résistant à la méticilline/classification , Staphylococcus aureus résistant à la méticilline/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne , Adulte d'âge moyen , Typage moléculaire , Facteurs de risque , Caractères sexuelsRÉSUMÉ
OBJECTIVE: The aim of this study was to compare the prevalence of periodontal pathogens, systemic inflammatory mediators and lipid profiles in type 1 diabetes children (DM) with those observed in children without diabetes (NDM), both with gingivitis. MATERIAL AND METHODS: Twenty-four DM children and twenty-seven NDM controls were evaluated. The periodontal status, glycemic and lipid profiles were determined for both groups. Subgingival samples of periodontal sites were collected to determine the prevalence of periodontal microorganisms by PCR. Blood samples were collected for IL-1-ß, TNF-α and IL-6 analysis using ELISA kits. RESULTS: Periodontal conditions of DM and NDM patients were similar, without statistical differences in periodontal indices. When considering patients with gingivitis, all lipid parameters evaluated were highest in the DM group; Capnocytophaga sputigena and Capnocytophaga ochracea were more prevalent in the periodontal sites of DM children. "Red complex" bacteria were detected in few sites of DM and NDM groups. Fusobacterium nucleatum and Campylobacter rectus were frequently found in both groups. Similar levels of IL-1-ß, TNF-α and IL-6 were detected in DM and NDM children. CONCLUSION: Clinical and immunological profiles are similar between DM and NDM children. The presence of Capnocytophaga sputigena and Capnocytophaga ochracea were associated with gingivitis in DM children.
Sujet(s)
Diabète de type 1/épidémiologie , Diabète de type 1/microbiologie , Gingivite/épidémiologie , Gingivite/microbiologie , Parodonte/microbiologie , Adolescent , Brésil/épidémiologie , Capnocytophaga/isolement et purification , Enfant , Cholestérol/sang , Denture permanente , Diabète de type 1/immunologie , Test ELISA , Femelle , Gingivite/immunologie , Humains , Interleukine-1 bêta/sang , Interleukine-6/sang , Mâle , Indice parodontal , Réaction de polymérisation en chaîne , Statistique non paramétrique , Dent de lait/microbiologie , Triglycéride/sang , Facteur de nécrose tumorale alpha/sangRÉSUMÉ
Abstract Objective The aim of this study was to compare the prevalence of periodontal pathogens, systemic inflammatory mediators and lipid profiles in type 1 diabetes children (DM) with those observed in children without diabetes (NDM), both with gingivitis. Material and methods Twenty-four DM children and twenty-seven NDM controls were evaluated. The periodontal status, glycemic and lipid profiles were determined for both groups. Subgingival samples of periodontal sites were collected to determine the prevalence of periodontal microorganisms by PCR. Blood samples were collected for IL-1-β, TNF-α and IL-6 analysis using ELISA kits. Results Periodontal conditions of DM and NDM patients were similar, without statistical differences in periodontal indices. When considering patients with gingivitis, all lipid parameters evaluated were highest in the DM group; Capnocytophaga sputigena and Capnocytophaga ochracea were more prevalent in the periodontal sites of DM children. “Red complex” bacteria were detected in few sites of DM and NDM groups. Fusobacterium nucleatum and Campylobacter rectus were frequently found in both groups. Similar levels of IL-1-β, TNF-α and IL-6 were detected in DM and NDM children. Conclusion Clinical and immunological profiles are similar between DM and NDM children. The presence of Capnocytophaga sputigena and Capnocytophaga ochracea were associated with gingivitis in DM children.
Sujet(s)
Humains , Mâle , Femelle , Enfant , Adolescent , Parodonte/microbiologie , Diabète de type 1/microbiologie , Diabète de type 1/épidémiologie , Gingivite/microbiologie , Gingivite/épidémiologie , Dent de lait/microbiologie , Triglycéride/sang , Brésil/épidémiologie , Capnocytophaga/isolement et purification , Test ELISA , Indice parodontal , Réaction de polymérisation en chaîne , Cholestérol/sang , Interleukine-6/sang , Facteur de nécrose tumorale alpha/sang , Statistique non paramétrique , Denture permanente , Diabète de type 1/immunologie , Interleukine-1 bêta/sang , Gingivite/immunologieRÉSUMÉ
Type 1 diabetes (T1D) is an autoimmune disease that is triggered by both genetic and environmental factors, resulting in the destruction of pancreatic ß cells. The disruption of the intestinal epithelial barrier and consequent escape of microbial products may be one of these environmental triggers. However, the immune receptors that are activated in this context remain elusive. We show here that during streptozotocin (STZ)-induced T1D, the nucleotide-binding oligomerization domain containing 2 (NOD2), but not NOD1, participates in the pathogenesis of the disease by inducing T helper 1 (Th1) and Th17 cells in the pancreatic LNs (PLNs) and pancreas. Additionally, STZ-injected wild-type (WT) diabetic mice displayed an altered gut microbiota compared with vehicle-injected WT mice, together with the translocation of bacteria to the PLNs. Interestingly, WT mice treated with broad-spectrum antibiotics (Abx) were fully protected from STZ-induced T1D, which correlated with the abrogation of bacterial translocation to the PLNs. Notably, when Abx-treated STZ-injected WT mice received the NOD2 ligand muramyl dipeptide, both hyperglycemia and the proinflammatory immune response were restored. Our results demonstrate that the recognition of bacterial products by NOD2 inside the PLNs contributes to T1D development, establishing a new putative target for intervention during the early stages of the disease.
Sujet(s)
Diabète expérimental , Diabète de type 1 , Microbiome gastro-intestinal , Noeuds lymphatiques , Protéine adaptatrice de signalisation NOD2/immunologie , Pancréas , Animaux , Translocation bactérienne/génétique , Translocation bactérienne/immunologie , Diabète expérimental/génétique , Diabète expérimental/immunologie , Diabète expérimental/microbiologie , Diabète expérimental/anatomopathologie , Diabète de type 1/génétique , Diabète de type 1/immunologie , Diabète de type 1/microbiologie , Diabète de type 1/anatomopathologie , Noeuds lymphatiques/immunologie , Noeuds lymphatiques/microbiologie , Noeuds lymphatiques/anatomopathologie , Mâle , Souris , Souris knockout , Protéine adaptatrice de signalisation NOD2/génétique , Pancréas/immunologie , Pancréas/microbiologie , Pancréas/anatomopathologieRÉSUMÉ
Type 1 diabetes (T1D) is the second most frequent autoimmune disease in childhood. The long-term micro- and macro-vascular complications of diabetes are associated with the leading causes of disability and even mortality in young adults. Understanding the T1D etiology will allow the design of preventive strategies to avoid or delay the T1D onset and to help to maintain control after developing. T1D development involves genetic and environmental factors, such as birth delivery mode, use of antibiotics, and diet. Gut microbiota could be the link between environmental factors, the development of autoimmunity, and T1D. In this review, we will focus on the dietary factor and its relationship with the gut microbiota in the complex process involved in autoimmunity and T1D. The molecular mechanisms involved will also be addressed, and finally, evidence-based strategies for potential primary and secondary prevention of T1D will be discussed.
Sujet(s)
Maladies auto-immunes/immunologie , Diabète de type 1/immunologie , Régime alimentaire , Microbiome gastro-intestinal , Système immunitaire/microbiologie , Animaux , Maladies auto-immunes/microbiologie , Diabète de type 1/microbiologie , Diabète de type 1/prévention et contrôle , Modèles animaux de maladie humaine , Tube digestif/microbiologie , Humains , Système immunitaire/immunologieRÉSUMÉ
OBJECTIVES: To evaluate, in a group of patients with long-standing type 1 diabetes (DM1), an association of dyspepsia symptoms with: changes in the gastroduodenal mucosa, infection by Helicobacter pylori, glycemic control, and psychological and nutritional factors. SUBJECTS AND METHODS: A total of 32 patient with DM1 were studied (age: 38 ± 9 years; females: 25; diabetes duration: 22 ± 5 years). All patients answered a standardized questionnaire for the evaluation of gastrointestinal symptoms and underwent upper gastrointestinal endoscopy, with gastric biopsies for the evaluation of Helicobacter pylori infection. The presence of anxiety and depression was evaluated by the HAD scale. Nutritional parameters were BMI, arm and waist circumference, skinfold measurement, and body fat percentage. RESULTS: Upper endoscopy detected lesions in the gastric mucosa in 34.4% of the patients, with similar frequency in those with (n = 21) and without dyspepsia (n = 11). The patients with dyspepsia complaints showed greater frequency of depression (60% vs. 0%; p = 0.001), higher values for HbA1c (9.6 ± 1.7 vs. 8.2 ± 1.3%; p = 0.01) and lower values for BMI (24.3 ± 4.1 vs. 27.2 ± 2.6 kg/m2; p = 0.02), body fat percentage (26.6 ± 6.2 vs. 30.8 ± 7.7%; p = 0.04), and waist circumference (78.7 ± 8 vs. 85.8 ± 8.1 cm; p = 0.02). No association was found between the symptoms and the presence of Helicobacter pylori. CONCLUSIONS: Dyspepsia symptoms in patients with long-standing DM1 were associated with glycemic control and depression, and they seem to negatively influence the nutritional status of these patients.
Sujet(s)
Diabète de type 1/complications , Dyspepsie/complications , Infections à Helicobacter/complications , Helicobacter pylori/isolement et purification , Troubles de l'humeur/complications , Adulte , Anxiété/métabolisme , Anxiété/microbiologie , Biopsie , Diabète de type 1/métabolisme , Diabète de type 1/microbiologie , Duodénum/métabolisme , Duodénum/microbiologie , Duodénum/anatomopathologie , Dyspepsie/microbiologie , Femelle , Muqueuse gastrique/métabolisme , Gastroscopie , Infections à Helicobacter/métabolisme , Humains , Mâle , Adulte d'âge moyen , Troubles de l'humeur/microbiologie , État nutritionnel , Estomac/microbiologie , Estomac/anatomopathologieRÉSUMÉ
Objectives To evaluate, in a group of patients with long-standing type 1 diabetes (DM1), an association of dyspepsia symptoms with: changes in the gastroduodenal mucosa, infection by Helicobacter pylori, glycemic control, and psychological and nutritional factors. Subjects and methods A total of 32 patient with DM1 were studied (age: 38 ± 9 years; females: 25; diabetes duration: 22 ± 5 years). All patients answered a standardized questionnaire for the evaluation of gastrointestinal symptoms and underwent upper gastrointestinal endoscopy, with gastric biopsies for the evaluation of Helicobacter pylori infection. The presence of anxiety and depression was evaluated by the HAD scale. Nutritional parameters were BMI, arm and waist circumference, skinfold measurement, and body fat percentage. Results Upper endoscopy detected lesions in the gastric mucosa in 34.4% of the patients, with similar frequency in those with (n = 21) and without dyspepsia (n = 11). The patients with dyspepsia complaints showed greater frequency of depression (60% vs. 0%; p = 0.001), higher values for HbA1c (9.6 ± 1.7 vs. 8.2 ± 1.3%; p = 0.01) and lower values for BMI (24.3 ± 4.1 vs. 27.2 ± 2.6 kg/m2; p = 0.02), body fat percentage (26.6 ± 6.2 vs. 30.8 ± 7.7%; p = 0.04), and waist circumference (78.7 ± 8 vs. 85.8 ± 8.1 cm; p = 0.02). No association was found between the symptoms and the presence of Helicobacter pylori. Conclusions Dyspepsia symptoms in patients with long-standing DM1 were associated with glycemic control and depression, and they seem to negatively influence the nutritional status of these patients. .
Sujet(s)
Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Diabète de type 1/complications , Dyspepsie/complications , Infections à Helicobacter/complications , Helicobacter pylori/isolement et purification , Troubles de l'humeur/complications , Anxiété/métabolisme , Anxiété/microbiologie , Biopsie , Diabète de type 1/métabolisme , Diabète de type 1/microbiologie , Duodénum/métabolisme , Duodénum/microbiologie , Duodénum/anatomopathologie , Dyspepsie/microbiologie , Gastroscopie , Infections à Helicobacter/métabolisme , Troubles de l'humeur/microbiologie , État nutritionnel , Estomac/métabolisme , Estomac/microbiologie , Estomac/anatomopathologieRÉSUMÉ
AIM: The aim of the present study was to analyze the occurrence of Porphyromonas gingivalis (P. gingivalis), Tannerella forsythia (T. forsythia), Treponema denticola (T. denticola), and Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) in patients with diabetes. METHODS: Periodontal and diabetic parameters and subgingival biofilm samples were obtained from 60 patients with diabetes and 62 patients without diabetes. By using polymerase chain reaction, the prevalence of red complex microorganisms (P. gingivalis, T. forsythia, and T. denticola) and A. actinomycetemcomitans were determined. Descriptive and non-parametric statistical analyses between groups were performed (Kruskal-Wallis, Mann-Whitney U-test, and Fisher's exact test). RESULTS: Patients with diabetes presented significantly higher periodontal attachment loss levels compared to patients without diabetes. Red complex microorganisms were detected in lower frequencies in patients with diabetes. The detection of A. actinomycetemcomitans was higher in patients with diabetes and periodontitis compared to systemically-healthy patients without periodontitis (P < 0.05). P. gingivalis was associated with periodontitis in non-diabetic patients (P < 0.05), whereas A. actinomycetemcomitans was associated with periodontitis in diabetic patients (P < 0.05). CONCLUSIONS: The findings of the present study indicate that there might be differences in the subgingival microbiota between diabetic and non-diabetic patients. In addition, P. gingivalis and A. actinomycetemcomitans were associated with periodontitis in patients without diabetes and patients with diabetes, respectively.
Sujet(s)
Aggregatibacter actinomycetemcomitans/isolement et purification , Bacteroides/isolement et purification , Diabète/microbiologie , Parodontite/microbiologie , Porphyromonas gingivalis/isolement et purification , Treponema denticola/isolement et purification , Adulte , Sujet âgé , Charge bactérienne , Biofilms , Études transversales , Plaque dentaire/microbiologie , Diabète de type 1/complications , Diabète de type 1/microbiologie , Diabète de type 2/complications , Diabète de type 2/microbiologie , Femelle , Humains , Mâle , Adulte d'âge moyen , Perte d'attache parodontale/microbiologie , Indice parodontal , Poche parodontale/microbiologie , Parodontite/complicationsRÉSUMÉ
BACKGROUND: Patients with diabetes mellitus (DM) are known to be prone to infection. However, the association between diabetes and chronic rhinosinusitis (CRS) has not been well studied. We sought to determine the effects of DM on CRS culture results and quality of life (QOL) after functional endoscopic sinus surgery (FESS). METHODS: We conducted a retrospective cohort study. Adult CRS patients undergoing FESS were recruited from October 1, 2007 to December 31, 2011. Patient demographics, comorbidities, medication use, and Lund-Mackay CT scores were collected prior to FESS. Intraoperative culture was obtained. Preoperative and 1-month, 3-month, and 6-month postoperative QOL was measured by scores on the 22-item Sinonasal Outcome Test (SNOT-22). A mixed effects model was performed for analysis. RESULTS: Among the 376 CRS patients included, 19 patients (5.05%) had DM. Compared to non-DM patients, DM patients were significantly more likely to have Pseudomonas aeruginosa (26.32% vs 7.56%; p = 0.004) and Gram-negative rods (26.32% vs 8.96%; p = 0.013), but there was no significant difference in the prevalence of Staphylococcus aureus; DM patients were also significantly more likely to have nasal polyps and gastroesophageal reflux disease. Additionally, DM patients had significantly less improvement of postoperative SNOT-22 scores from baseline to 6-month follow-up than non-DM patients (adjusted mean = 11.14, 95% CI (0.14, 22.15), p = 0.047) after adjusting for all the other risk factors for CRS. CONCLUSION: DM patients may be prone to Gram-negative bacterial sinus infections, and have significantly worse short-term postoperative QOL. Special postoperative care may need to be considered in CRS patients with DM.
Sujet(s)
Diabète de type 1/épidémiologie , Diabète de type 2/épidémiologie , Infections bactériennes à Gram négatif/épidémiologie , Rhinite/épidémiologie , Sinusite/épidémiologie , Adulte , Maladie chronique , Études de cohortes , Diabète de type 1/microbiologie , Diabète de type 1/chirurgie , Diabète de type 2/microbiologie , Diabète de type 2/chirurgie , Endoscopie , Femelle , Infections bactériennes à Gram négatif/microbiologie , Infections bactériennes à Gram négatif/chirurgie , Humains , Mâle , Adulte d'âge moyen , Sinus de la face/microbiologie , Sinus de la face/chirurgie , Pseudomonas aeruginosa/isolement et purification , Qualité de vie , Rhinite/microbiologie , Rhinite/chirurgie , Sinusite/microbiologie , Sinusite/chirurgie , Staphylococcus aureus/isolement et purificationRÉSUMÉ
Dysbiosis of the intestinal microbiota affecting the gut barrier could be triggering Type 1 Diabetes (T1D), the second most frequent autoimmune disease in childhood. This study compared the structure of the fecal microbiota in 29 mestizo children aged 7-18 years, including 8 T1D at onset, 13 T1D after 2 years treatment, and 8 healthy controls. Clinical information was collected, predisposing haplotypes were determined; the fecal DNA was extracted, the V4 region of the 16S rRNA gene amplified and 454-pyrosequenced. The newly diagnosed T1D cases had high levels of the genus Bacteroides (p < 0.004), whereas the control group had a gut microbiota dominated by Prevotella. Children with T1D treated for ≥2 years had levels of Bacteroides and Prevotella compared to those of the control group. The gut microbiota of newly diagnosed T1D cases is altered, but whether it is involved in disease causation or is a consequence of host selection remains unclear.
Sujet(s)
Bactéries/classification , Bactéries/génétique , Diabète de type 1/microbiologie , Fèces/microbiologie , Microbiote , Adolescent , Études cas-témoins , Enfant , Biologie informatique , Études transversales , ADN bactérien/génétique , Femelle , Études de suivi , Tube digestif/microbiologie , Humains , Mâle , Mexique , Pronostic , ARN ribosomique 16S/génétiqueRÉSUMÉ
INTRODUCTION: Type 1 diabetes mellitus (T1DM) is associated with various oral complications. However there is no consensus regarding the association of T1DM and caries. AIM OF THE STUDY: Critical revision of dental caries-associated risk factors and type 1 diabetes mellitus. MATERIALS AND METHODS: Search of the MEDLINE and LILACS databases from 2000 to 2010, using, in different combination, the key words "dental caries", "diabetes mellitus" and "type 1 diabetes mellitus". RESULTS: The association between T1DM and dental caries remains controversial. Although some studies demonstrate a higher prevalence of caries due to the increased concentration of salivary glucose, acidity of the oral cavity, salivary viscosity, reduced salivary flow rate, and salivary gland dysfunction; other studies report a reduction of caries levels, probably caused by decreased ucrose ingestion. CONCLUSIONS: Although patients with uncontrolled T1DM and poor oral hygiene may present increased prevalence of dental caries, the literature does not describe a consistent relationship between T1DM and dental caries. Further investigations are warranted. If a true association is substantiated, intervention studies to prevent or reduce the occurrence of caries in this population should follow.
Sujet(s)
Caries dentaires/épidémiologie , Diabète de type 1/épidémiologie , État de santé , Hygiène buccodentaire , Comorbidité , Caries dentaires/microbiologie , Susceptibilité à la carie dentaire , Diabète de type 1/microbiologie , Hémoglobine glyquée/analyse , Humains , Prévalence , Facteurs de risque , Salive/microbiologieRÉSUMÉ
OBJECTIVE: The goal of the study was to measure the prevalence of Candida spp. in the oral cavity of patients with diabetes types 1 and 2 when compared to healthy individuals and to study antifungal resistance profile of the isolates. DESIGN: There were 162 subjects in the study: diabetes type 1 (n=39); control group 1 (n=50): healthy individuals matched in gender, age, and oral conditions to diabetes type 1 patients; diabetes type 2 (n=37); control group 2 (n=36) who were matched to each patient of the diabetes type 2 group. Stimulated saliva was collected and isolates were identified with phenotypic tests. The presence of C. dubliniensis was determined by multiplex PCR. RESULTS: There were no statistically significant differences in Candida spp. frequency between the diabetes 1 group and its control (p=0.443) nor between the diabetes 2 group and its control (p=0.429). C. albicans was the most frequently isolated yeast in all groups. In the diabetes groups, C. stellatoidea, C. parapsilosis, C. tropicalis, C. lipolytica, C. glabrata, and C. krusei were also identified. Additionally, in control groups, C. kefyr was also detected. None of the isolates were resistant to amphotericin B and flucytosine. A low percentage of the isolates were resistant to ketoconazole. CONCLUSIONS: No differences were detected in colonization of Candida spp. oral isolates from type 1 and type 2 diabetes when compared to matched controls. The antifungal resistance of Candida spp. isolates for ketoconazole from type 1 diabetes patients was significantly higher than that of its matched control.
Sujet(s)
Antifongiques/pharmacologie , Candida/effets des médicaments et des substances chimiques , Candida/isolement et purification , Candidose buccale/traitement médicamenteux , Candidose buccale/microbiologie , Diabète de type 1/microbiologie , Diabète de type 2/microbiologie , Kétoconazole/pharmacologie , Bouche/microbiologie , Adolescent , Adulte , Sujet âgé , Études cas-témoins , Enfant , Résistance des champignons aux médicaments , Femelle , Humains , Mâle , Tests de sensibilité microbienne , Adulte d'âge moyen , Réaction de polymérisation en chaîne , PrévalenceRÉSUMÉ
BACKGROUND: An increased number of intraepithelial lymphocytes (IELs) can be the only histological feature in early stages of celiac disease (CD). This is also presented in duodenum of patients with Helicobacter pylori-associated gastritis and in autoimmune diseases. Because CD is frequently associated with type 1 diabetes mellitus, we analyzed the density of IELs in the distal duodenum of non-celiac diabetic patients associated or not with H.pylori infection. METHODS: IEL density and the presence of H.pylori were determined in biopsies of the distal duodenum and gastric antrum and body obtained from Brazilian diabetic adolescents who were negative for anti-human tissue transglutaminase and anti-endomysial. The results were compared with the histological findings of gastric and duodenal biopsies obtained from non-diabetic older children and adolescents. RESULTS: H.pylori was detected in 33.3% of diabetic patients and in 56.7% of the control group. No association was observed between the presence of H.pylori and an increased lymphocyte density in the distal duodenum in either group. Diabetic patients presented a duodenal IEL density similar to that of the control group. Lymphocytic gastritis was not identified in any of the biopsies analyzed. CONCLUSIONS: The density of IELs in the distal duodenum of diabetic adolescents did not differ from that observed in older children and adolescents without this autoimmune disease. H.pylori infection, which is frequent among adolescents from developing countries, did not modify lymphocyte density in the distal duodenum in the absence of lymphocytic gastritis.
Sujet(s)
Diabète de type 1/anatomopathologie , Duodénum/anatomopathologie , Gastrite/anatomopathologie , Infections à Helicobacter/anatomopathologie , Hyperlymphocytose/anatomopathologie , Adolescent , Brésil , Diabète de type 1/immunologie , Diabète de type 1/microbiologie , Duodénum/cytologie , Femelle , Gastrite/immunologie , Gastrite/microbiologie , Infections à Helicobacter/immunologie , Infections à Helicobacter/microbiologie , Helicobacter pylori/croissance et développement , Helicobacter pylori/immunologie , Humains , Immunohistochimie , Numération des lymphocytes , Hyperlymphocytose/immunologie , Hyperlymphocytose/microbiologie , MâleRÉSUMÉ
The aim of this study is to describe the degree of yeast-colonization in diabetic and hemodialysed-users of dental prostheses. Individuals (306) were examined using an oral rinse technique in order to evaluate the incidence of yeast-carriage, and genotype of C. albicans. Yeasts were isolated from 68.4% (91/133) individual's dental prostheses users. Dental prostheses were found to be a significant factor for the yeast colonization (P < 0.05). Overall, the intensity of carriage was higher in diabetic patients as compared with health and hemodialysed individuals (P < 0.05). The isolation rates were: C. albicans (51.7%), C. parapsilosis (20.9%), C. tropicalis (14.3%), C. glabrata (6.6%), C. krusei (3.3%), C. rugosa (1.1%), and Pichia (Pichia ohmeri, 2.2%). Ready-To-Go RAPD Analysis Beads were used and primer OPJ 6 distinguished the C. albicans isolates found in prostheses users. All the isolates were grouped into 11 RAPD profiles in four main clusters and, the average S (AB) for the entire collection of 47 C. albicans isolates were 0.779 +/- 0.178. Over 85% of isolates had a similarity level higher than or equal to 0.8 reinforcing the idea that the use of dental prostheses, independently of the host's clinical condition, probably provides the necessary conditions for these strains to gain a growth-specific advantage over others.
Sujet(s)
Candida albicans/génétique , Candidose buccale/microbiologie , Appareils de prothèse dentaire , Diabète de type 1/microbiologie , Maladies de la bouche/microbiologie , Dialyse rénale , Brésil , Candida albicans/croissance et développement , Candida albicans/isolement et purification , Candidose buccale/complications , Études de cohortes , ADN fongique/composition chimique , Humains , Maladies de la bouche/complications , Phylogenèse , Technique RAPDSujet(s)
Anticorps antibactériens/sang , Diabète de type 1/microbiologie , Interleukine-8/sang , Staphylococcus aureus , Adulte , Sujet âgé , Argentine , Études cas-témoins , Diabète de type 1/complications , Femelle , Humains , Immunoglobuline A , Mâle , Adulte d'âge moyen , Staphylococcus aureus/immunologie , Staphylococcus aureus/isolement et purificationRÉSUMÉ
PURPOSE: To determine the mycobiota of the healthy conjunctiva in diabetic individuals, according to diabetes type, age, sex, disease time, type of treatment, and stage of diabetic retinopathy of the individuals. To identify the anemophilus mycobiota in the sampling rooms. METHODS: A cross-sectional study was carried out on 803 diabetics who reside in the urban area of São Paulo-SP/Brazil. Sabouraud's dextrose agar culture with chloramphenicol was used for primoisolation, and the key of De Hoog was used to identify filamentous fungi. RESULTS: Of the evaluated diabetics, 6.6% (53/803) presented type 1 diabetes and 93.4% (750/803) type 2. The positive cultures for fungi in the conjunctiva of diabetics was 4.2% (34/803), with 1.9% (1/53) in type 1 diabetics and 4.4% (33/740) in type 2 diabetics (p=0.720). With respect to the presence or not of isolated fungi, there was no statistically significant association regarding age (p=0.575), sex (p=0.517), disease time (p=0.633), type of treatment (p=0.422), and diabetic retinopathy stage (p=0.655) of the tested individuals. The identified fungi were all filamentous: Aspergillus spp. represented 59.5% (25/42) of isolations and 47.6% (20/42) of isolated species were Aspergillus niger. Growth of anemophilus fungi occurred in the air of the room and coincidences were observed between the isolated species from the air and those from the conjunctiva. CONCLUSIONS: Presence of mycobiota in healthy conjunctivas of diabetics was identified, with no significant association between the greater number of positive fungi isolations and the type of diabetes, age, sex, disease type, type of treatment, and stage of diabetic retinopathy. In the collection rooms, anemophilus mycobiota was identified.
Sujet(s)
Conjonctive/microbiologie , Diabète de type 1/microbiologie , Diabète de type 2/microbiologie , Rétinopathie diabétique/microbiologie , Deuteromycota/isolement et purification , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Études transversales , Femelle , Humains , Mâle , Adulte d'âge moyen , Deuteromycota/classification , Population urbaineRÉSUMÉ
OBJETIVOS: Determinar a micobiota de conjuntiva sadia em indivíduos diabéticos, segundo tipo de diabetes, idade, sexo, tempo de doenca, tipo de tratamento e estádio da retinopatia. Estabelecer a micobiota anemófila nas salas de colheita. MÉTODOS: Estudo transversal de 803 diabéticos residentes na zona urbana de São Paulo - SP/Brasil. Foi usado para primo-isolamento o meio de cultivo ágar Sabouraud dextrose com cloranfenicol e para identificacão dos fungos filamentosos a chave de De Hoog. RESULTADOS: Dos diabéticos avaliados, 6,6 por cento (53/803) apresentavam diabetes tipo 1 e 93,4 por cento (750/803) tipo 2. Os cultivos positivos para fungos em conjuntiva de diabéticos foi 4,2 por cento (34/803), sendo 1,9 por cento (1/53) nos diabéticos tipo 1 e 4,4 por cento (33/740) nos diabetes tipo 2 (p=0,720). Não foi verificada associacão estatisticamente significante quanto à presenca ou não de isolamentos de fungos em relacão idade (p=0,575), sexo (p=0,517), tempo de doenca (p=0,633), tipo de tratamento (p=0,422) e estádio de retinopatia diabética (p=0,655) desses indivíduos. Todos os fungos identificados foram filamentosos: Aspergillus spp. representou 59,5 por cento (25/42) dos isolamentos sendo 47,6 por cento (20/42) Aspergillus niger. Ocorreu crescimento de fungos anemófilos do ar ambiente da sala, observando-se coincidências entre as espécies isoladas no ar e na conjuntiva. CCONCLUSÕES: Foi identificada presenca de micobiota em conjuntiva sadia de diabéticos, não havendo associacão entre a maior positividade de isolamentos fúngicos e o tipo de diabetes, idade, sexo, tempo de doenca, tipo de tratamento e estádio da retinopatia diabética. Nas salas de colheita foi identificada micobiota anemófila.
Sujet(s)
Humains , Mâle , Femelle , Adolescent , Adulte , Adulte d'âge moyen , Sujet âgé de 80 ans ou plus , Conjonctive/microbiologie , Diabète de type 1/microbiologie , /microbiologie , Rétinopathie diabétique/microbiologie , Deuteromycota/isolement et purification , Études transversales , Deuteromycota/classification , Population urbaineRÉSUMÉ
Comparou-se pacientes diabéticos tipo 1 com pacientes controles saudáveis, para avaliar as condições periodontais e da mucosa, identificar, qualificar e inter-relacionar, com o nível glicêmico do diabético, a presença de leveduras na gengiva e na saliva, através de: teste de hemoglobina glicosilada, índice de placa, índice gengival, índice de sangramento gengival, o nível de inserção, a profundidade de sondagem, exame radiográfico, inspeção da mucosa, teste de fluxo salivar e exame microbiológico. As diferenças não foram significantes quanto às condições periodontais e de mucosa, entre os pacientes, nem quanto à prevalência de leveduras entre os locais amostrados, exceto que os pacientes diabéticos mais velhos apresentaram nível de inserção clínica 77% maior que os mais jovens e o dobro de leveduras que os demais grupos. A C. albicans foi a levedura mais freqüente. Concluiu-se que houve uma leve tendência dos pacientes diabéticos apresentarem uma susceptibilidade aumentada à doença periodontal e maior frequência de leveduras, não podendo generalizar e estender os resultados de uma população tão pequena, sugerindo que se avalie uma população maior.(AU)
This work assessed (a) the differences of periodontal and soft tissue conditions, between diabetics type 1 patients, (b) the prevalence and comparison of yeast in gingival and saliva, (c) possible association between yeast with glycaemic conditions of the diabetic patients. Twenty-four patients were subdivided in 3 groups: diabetic subjects aging from 13 to 19 years (A) and aging from 20 or more years (B) and healthy controls (C) with periodontal diseases, aging from 20 or more years. There were performed the hemoglobin glycated test, radiological examination, anamnestic information, periodontal and soft tissues condition, salivary flow and microbiological analysis of the gingival and saliva; the plaque index, gingival index, bleeding sulcular index, clinical attachment level and probing depth were recorded. There were no significant differences in relation to the periodontal and mucosa conditions between diabetic patients, exception was to group B that showed 77% more attachment loss than group A. The results showed no significant differences in the prevalence of yeast, however there were twice more numbers of yeast in group B. C. albicans was the most frequent detected yeast. Although data from this study were not significant, a slightly tendency to a high prevalence of yeast and an increased susceptibility to periodontal diseases in diabetic population were shown. So, it would be prudent to elucidate in a greater population.(AU)
Sujet(s)
Humains , Mâle , Femelle , Enfant , Adolescent , Adulte , Diabète de type 1/complications , Diabète de type 1/microbiologie , Gencive/microbiologie , Muqueuse de la bouche/microbiologie , Maladies parodontales/microbiologie , Candida albicans/isolement et purification , Études cas-témoins , Indice glycémique , Indice parodontal , Répartition par sexe , Statistique non paramétriqueRÉSUMÉ
The prevalence of Actinobacillus Actinomycetemcomitans (Aa) in subgingival plaque specimens from 26 insulin-dependent diabetes mellitus patients, 11-25 years of age, was determined between January 1987 and December 1989. One hundred and thirty subgingival plaque samples were collected with sterile periodontal curettes. The specimens were weighed, diluted, inoculated on trypticase-soy-serum-bacitracin-vancomycin agar medium (TSBV) and incubated under microaerophilic conditions. Aa was isolated from 2.3//of healthy periodontal areas in these patients, while the microorganism was found in 12.5//of the sites with gingivitis and in 2.6//of the periodontal pockets examined. Although biochemical tests used for the characterization of Aa strains showed homogeneous results, different biotypes were isolated from one or more periodontal sites in the same patient
Sujet(s)
Humains , Mâle , Femelle , Enfant , Adolescent , Adulte , Actinobacillus/isolement et purification , Plaque dentaire , Diabète de type 1/microbiologie , Parodontite/microbiologieRÉSUMÉ
Estudio bacteriológico realizado en pacientes diabéticos insulino dependientes y no insulino dependientes que asisten al Patronato contra la Diabetes, en el período comprendido de Junio a Julio de 1987. Las infecciones causadas por Staphylococcus aureus han constitutido una muy seria preocupación para médicos y epidemiologos, por la gravedad que representan especialmente para diabéticos; en quiens se ha demostrado que el estado del portador es fuente de infección frecuente representado riesgo de diseminación para ellos y otros pacientes. (1) En este trabajo se investigaron 120 pacientes diabéticos, pudiéndose establecer que la frecuencia del estado portador varía significativamente en relación a los datos que se tienen de la población en general, que la presencia de Staphylococcus a nivel nasal es mayor en frecuencia los pacientes diabéticos insulinos dependientes (Tipo I) que en no dependientes, además que el patrón de susceptibilidad a los antimicrobianos varió notablemente entre un grupo y otro, la resistencia a las penicilinas G y a la oxacilina es dos veces mayor en cepas aisladas en pacientes insulino dependientes